Interestingly, H19 interacts with 4E-BP1 at the TOS motif and inhibits 4E-BP1 binding to Raptor competitively, implying that inhibition of pituitary tumors by H19 is more effective compared with carte blanche treatment [41]. The gene discussed is RPTOR; the disease is pituitary tumor.